Children's Oncology Group

Recent papers from Children's Oncology Group

1. Feasibility and Tolerability of Chemoimmunotherapy Given During Induction for Treatment of Patients With High-Risk Neuroblastoma: A Report From the Children's Oncology GroupJournal of Clinical Oncology · 2026
2. Phase II study of selpercatinib in children and young adults with RET-altered tumors: Arm N of the NCI-COG Pediatric MATCH trial (APEC1621)The Oncologist · 2026
3. A phase 2 study of tipifarnib in children and young adults with tumors harboring HRAS genomic alterations: NCI-COG Pediatric MATCH trial (APEC1621M)The Oncologist · 2026
4. Impact of Extent of Surgical Resection on Survival in Patients With High-risk NeuroblastomaAnnals of Surgery · 2026
5. Quality of Life in Ukrainian Children and Adolescents with Cancer Relocated to Switzerland During the Russian–Ukrainian War: An Exploratory Multicenter StudyCurrent Oncology · 2026
6. Case Report: Activated phosphoinositide 3-kinase δ syndrome mimicking Hyper-IgM syndrome: early hepatosplenomegaly as a key diagnostic clueFrontiers in Immunology · 2026
7. Evaluating the Prognostic Relevance of Pre-Treatment Epstein–Barr Virus Levels in Non-Endemic Pediatric Nasopharyngeal CarcinomaCancers · 2026
8. Profile of individuals with full-scale intelligence quotient (FSIQ) scores in the National Spina Bifida Patient Registry (NSBPR)Journal of Pediatric Rehabilitation Medicine · 2026
9. Sociodemographic Factors Associated With Later Stage at Diagnosis of Pediatric Germ Cell Tumors: A Report From Children's Oncology Group Registries ACCRN07 and APEC14B1Pediatric Blood & Cancer · 2026
10. Social support experiences and unmet needs of grandparents following a grandchild’s cancer diagnosis: A two-year longitudinal mixed-methods study (The GROkids project)EJC Paediatric Oncology · 2026
11. Factors Impacting Overall Survival Post‐Relapse in High‐Risk Neuroblastoma: Children's Oncology Group Outcomes From 2000 to 2019Pediatric Blood & Cancer · 2026
12. ID #1199 The Childhood Cancer Data Initiative: Molecular Characterization Initiative (MCI) Platform for Advancing Precision Diagnosis and Discovery in Pediatric CNS TumorsNeuro-Oncology Pediatrics · 2026
13. ID #1019 Initial Results from a Phase 1/2 Trial of Selinexor and Radiation in Newly Diagnosed Pediatric High-Grade Glioma and Diffuse Midline Glioma: A Children’s Oncology Group TrialNeuro-Oncology Pediatrics · 2026
14. Distributional effects of female employment ratio on Turkish labor market outcomesJournal of Economic Studies · 2026
15. A Bayesian‐Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in NeuroblastomaClinical and Translational Science · 2026
16. Who Leads, Who Treats, What Dose? European Paediatric DTC Practice – an EXPeRT surveyEuropean Journal of Endocrinology · 2026
17. Toxicity from asparaginase during acute lymphoblastic leukemia induction: A report from the Children's Oncology GroupBlood Advances · 2026
18. Integrated Molecular, Genomic, and Clinical Characterization of Pediatric and Adolescent Translocation Renal Cell Carcinoma: A Report from the Children’s Oncology GroupBiomedicines · 2026
19. Exploring the Use of Traditional and Complementary Medicine in Pediatric Oncology: A Mixed‐Methods Study From UgandaPediatric Blood & Cancer · 2026
20. Longitudinal Analysis of Psychological Distress in Grandparents of Children With Cancer: Results From a Multicenter Cohort Study in Switzerland ( GROKids Project)Cancer Medicine · 2026